CLEAR GENE INC
Moss Beach, CA · Medtech · Private
Molecular diagnostic panel detecting residual breast cancer disease through biomarkers
- Grants
- $586K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 3 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Molecular Analysis of Residual Breast Cancer | $293,237 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Molecular Analysis of Residual Breast Cancer | $293,237 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2087 | ACOUSTIC MEDSYSTEMS, INC. | — | — |
| 2088 | ALTYX SURGICAL, INC. | — | — |
| 2089 | REDWOOD NEURO INC. | — | — |
| 2090 | CLEAR GENE INC | — | — |
| 2091 | PRIVO TECHNOLOGIES, LLC | — | — |
| 2092 | XL Sci Tech Inc | — | — |
| 2093 | VDF INDUSTRIES INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods And Compositions For The Analysis Of Cancer Biomarkersgranted
- Methods, Compositions, Kits And Devices For Rapid Analysis Of Biological Markersapplication
- Methods, Compositions, And Devices For Rapid Analysis Of Biological Markersapplication
- Methods, Compositions, Kits And Devices For Rapid Analysis Of Biological Markersgranted
- Methods, Compositions, And Devices For Rapid Analysis Of Biological Markersgranted
- Methods, Compositions, Kits And Devices For Rapid Analysis Of Biological Markersapplication
- Methods, Compositions, And Devices For Rapid Analysis Of Biological Markersapplication
- Methods and Compositions for Rapid Point-of-care Analysis of Biologic Markersapplication
- Methods and Compositions for Rapid Point-of-care Analysis of Biologic Markersapplication
- Methods and Compositions for Rapid Point-of-care Analysis of Biologic Markersapplication
- Methods And Compositions For The Analysis Of Cancer Biomarkersapplication
- Methods And Compositions For The Analysis Of Cancer Biomarkersapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.